Iron in Vascular Calcification: Pro-Calcific Agent or Protective Modulator?
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010210 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Enikő Balogh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Pathophysiology Research Group, Research Centre for Molecular Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Vascular Calcification, Iron. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, the Hungarian National Research, Development, and Innovation Office.
Abstract (Originalsprache)
Vascular calcification is a complex, regulated process characterized by the pathological deposition of calcium phosphate minerals in the vascular wall, contributing to cardiovascular morbidity and mortality, particularly in patients with chronic kidney disease (CKD), diabetes, and aging. Once thought to be a passive degenerative process, it is now recognized as an active, cell-mediated phenomenon that shares molecular features with bone formation. Beyond traditional risk factors such as hyperphosphatemia and inflammation, disturbances in iron metabolism have recently emerged as modulators of vascular calcification. Iron, a vital trace element involved in numerous cellular functions, exhibits a dual role as both a potential driver and inhibitor of calcification, depending on its dose, distribution, and cellular context. In this review, we summarize in vitro and in vivo studies investigating the impact of iron on the osteochondrogenic differentiation and calcification of vascular smooth muscle cells and valve interstitial cells. We further highlight mechanistic insights that may explain the divergent findings reported in the literature. Finally, we compile clinical evidence linking disturbances in iron metabolism with coronary artery calcification and cardiovascular mortality in CKD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vascular Pathophysiology Research Group, Research Centre for Molecular Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
ORCID-Profile: Enikő Balogh, Andrea Tóth
Förderung
- National Research, Development and Innovation Office
- the Hungarian National Research, Development, and Innovation Office
Zitieren
APA
Balogh, E., Tóth, A., & Jeney, V. (2025). Iron in Vascular Calcification: Pro-Calcific Agent or Protective Modulator?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010210
Vancouver
Balogh E, Tóth A, Jeney V. Iron in Vascular Calcification: Pro-Calcific Agent or Protective Modulator?. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010210
BibTeX
@article{Balogh2025,
author = {Balogh, Enikő and Tóth, Andrea and Jeney, Viktória},
title = {Iron in Vascular Calcification: Pro-Calcific Agent or Protective Modulator?},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010210}
}
EUVIMED